Genetik autistischer Störungen
Abstract
Zusammenfassung: Autistische Störungen sind heterogene Erkrankungen. Die Betroffenen zeigen Einschränkungen der Kommunikation und sozialen Interaktion und stereotypes, repetitives Verhalten sowie Sonderinteressen. Der überwiegende Teil der autistischen Störungen sind genetisch bedingt. In dem Artikel wird eine Übersicht über zytogenetische Veränderungen sowie molekulargenetische Kopplungs- und Assoziationsstudien gegeben. Wichtige Differentialdiagnosen werden beschrieben. Die Ergebnisse dieser Studien haben eine besondere Bedeutung für die genetische Beratung der Familien.
Summary: Autistic disorders are heterogeneous. Affected individuals show impairments in communication and social interaction, as well as stereotypic, repetitive behaviour and special interests. The majority of autistic disorders are genetic in origin. The current article presents an overview of cytogenetic findings, as well as of results of molecular genetic linkage and association studies. Important differential diagnoses will be described. The results of genetic studies are especially relevant with regard to genetic counselling for affected families. Key words: autistic disorders, genetics, linkage, association, cytogenetic, genetic counselling
Literatur
1989). Elevated blood serotonin in autistic probands and their first-degree relatives. Journal of Autism and Developmental Disorders, 19, 397– 407
(1994). Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association
(1944). Die «Autistischen Psychopathen» im Kindesalter. Archiv für Psychiatrie und Nervenkrankheiten, 117, 73– 136
(2002). Regional meta-analysis of published data supports linkage of autism with markers on chromosome 7. Molecular Psychiatry, 7, 56– 66
(1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychological Medicine, 25, 63– 77
(2006). Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet, 368, 210– 215
(2005). Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. American Journal of Human Genetics, 77, 851– 868
(2004). Chromosome 15q11-13 abnormalities and other medical conditions in individuals with autism spectrum disorders. Psychiatric Genetics, 14, 131– 137
(2006). A genetic variant that disrupts MET transcription is associated with autism. Proceedings of the National Academy of Sciences of the United States of America, 103, 16834– 16839
(2006). En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder. Brain Research, 1116, 166– 176
(2005). Specific genetic disorders and autism: clinical contribution towards their identification. Journal of Autism and Developmental Disorders, 35, 103– 116
(2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics, 39, 25– 27
(2007). A quantitative trait locus analysis of social responsiveness in multiplex autism families. American Journal of Psychiatry, 164, 656– 662
(1998). Localisation of a gene implicated in a severe speech and language disorder. Nature Genetics, 18, 168– 170
(2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. Journal of Autism and Developmental Disorders, 33, 365– 382
(2007). The genetics of autistic disorders and its clinical relevance: a review of the literature. Molecular Psychiatry, 12, 2– 22
(2006). Oxytocin, vasopressin and pair bonding: implications for autism. Philosophical Transaction of the Royal Society London B Biological Sciences, 361, 2187– 2198
(1997). Annotation: tuberous sclerosis. Journal of Child Psychology and Psychiatry, 38, 603– 614
(2001). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. American Journal of Human Genetics, 69, 570– 581
(2007). Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neuroscience Letters, 417, 6– 9
(2002). Linkage and association of the glutamate receptor 6 gene with autism. Molecular Psychiatry, 7, 302– 310
(1943). Autistic disturbance of affective contact. Nervous Child, 2, 217– 250
(2007). Family-based association study between GRIK2 polymorphisms and autism spectrum disorders in the Korean trios. Neuroscience Research, 58, 332– 335
(2006). Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol. Psychiatry, 11, 1073– 1084
(2004). X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. American Journal of Human Genetics, 74, 552– 557
(1999). Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey. Journal of Child Psychology and Psychiatry, 40, 335– 345
(2007). Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neuroscience and Biobehavioral Reviews, 31, 315– 326
(2007). Dissecting the locus heterogeneity of autism: significant linkage to chromosome 12q14. Molecular Psychiatry, 12, 376– 384
(2004). A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism. American Journal of Medical Genetetics B Neuropsychiatric Genetics, 131, 51– 59
(2005). Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors. Journal of Genetic Counselling, 14, 249– 270
(2006). Genetic counseling and ethical issues for autism. American Journal of Medical Genetics C Seminars in Medical Genetics, 142, 52– 57
(1999). Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Human Mutation, 14, 412– 422
(2004). Rett syndrome: clinical and molecular update. Current Opinion in Pediatrics, 16, 670– 677
(2006). Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update. European Journal of Medical Genetics, 49, 9– 18
(2000). Neural cell response to multiple novel sites on laminin-1. Journal of Neuroscience Research, 61, 302– 312
(2004). Diagnosis of tuberous sclerosis complex. Journal of Child Neurology, 19, 643– 649
(1998). Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. Journal of Medical Genetics, 35, 558– 565
(2006). Evidence for multiple loci from a genome scan of autism kindreds. Molecular Psychiatry, 11, 1049– 1060 979
(1998). Autism and maternally derived aberrations of chromosome 15q. American Journal of Medical Genetics, 76, 327– 336
(2007). Strong Association of De Novo Copy Number Mutations with Autism. Science, 316, 445– 449
(2004). Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. American Journal of Medical Genetics B Neuropsychiatric Genetics, 131, 48– 50
(2006). The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. American Journal of Medical Genetics A, 140, 1511– 1518
(1998). Genetic counseling in autism and pervasive developmental disorders. Journal of Autism and Developmental Disorders, 28, 447– 456
(2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319– 328
(2006). Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Molecular Psychiatry, 11, 18– 28
(1992). The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organisation
(2005). Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biological Psychiatry, 58, 74– 77
(